{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:31:51Z","timestamp":1792549911405,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003356","name":"Gazi \u00dcniversitesi","doi-asserted-by":"publisher","award":["01 \/ 2018 - 30"],"award-info":[{"award-number":["01 \/ 2018 - 30"]}],"id":[{"id":"10.13039\/501100003356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00702-022-02553-x","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T14:02:30Z","timestamp":1667656950000},"page":"1513-1526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study"],"prefix":"10.1007","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4336-2517","authenticated-orcid":false,"given":"Niyazi Samet","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayram","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukiye Filiz","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selcuk","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Ekmekci Ertek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruz","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Cicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Bolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemal","family":"Kocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemal","family":"Cevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"Bukan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,5]]},"reference":[{"issue":"5","key":"2553_CR1","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.brs.2019.05.018","volume":"12","author":"TI Aarsland","year":"2019","unstructured":"Aarsland TI, Leskauskaite I, Midttun \u00d8, Ulvik A, Ueland PM, Oltedal L, Erchinger VJ, Oedegaard KJ, Haavik J, Kessler U (2019) The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites. Brain Stimul 12(5):1135\u20131142","journal-title":"Brain Stimul"},{"issue":"6","key":"2553_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/bs12060195","volume":"12","author":"MK Adu","year":"2022","unstructured":"Adu MK, Shalaby R, Chue P, Agyapong VI (2022) Repetitive transcranial magnetic stimulation for the treatment of resistant depression: a scoping Review. Behav Sci 12(6):195","journal-title":"Behav Sci"},{"key":"2553_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpsychires.2018.02.011","volume":"100","author":"AP Allen","year":"2018","unstructured":"Allen AP, Naughton M, Dowling J, Walsh A, O\u2019Shea R, Shorten G, Scott L, McLoughlin D, Cryan JF, Clarke G (2018) Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: comparison of multiple ketamine infusions and electroconvulsive therapy. J Psychiatr Res 100:24\u201332","journal-title":"J Psychiatr Res"},{"key":"2553_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-019-00857-9","volume-title":"Scientists rise up against statistical significance","author":"V Amrhein","year":"2019","unstructured":"Amrhein V, Greenland S, McShane B (2019) Scientists rise up against statistical significance. Nature Publishing Group, Berlin"},{"key":"2553_CR5","doi-asserted-by":"publisher","DOI":"10.3187\/DCNS.2011.13.1\/cbaeken","author":"C Baeken","year":"2022","unstructured":"Baeken C, De Raedt R (2022) Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neuro circuitry in unipolar depression. Dialogues Clin Neurosci. https:\/\/doi.org\/10.3187\/DCNS.2011.13.1\/cbaeken","journal-title":"Dialogues Clin Neurosci"},{"key":"2553_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2022.946263","author":"S Battaglia","year":"2022","unstructured":"Battaglia S, Cardellicchio P, Di Fazio C, Nazzi C, Fracasso A, Borgomaneri S (2022a) The influence of vicarious fear-learning in \u2018infecting\u2019reactive action inhibition. Front Behav Neuroscie. https:\/\/doi.org\/10.3389\/fnbeh.2022.946263","journal-title":"Front Behav Neuroscie"},{"key":"2553_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2022.998714","author":"S Battaglia","year":"2022","unstructured":"Battaglia S, Cardellicchio P, Di Fazio C, Nazzi C, Fracasso A, Borgomaneri S (2022b) Stopping in (e) motion: reactive action inhibition when facing valence-independent emotional stimuli. Front Behav Neuroscie. https:\/\/doi.org\/10.3389\/fnbeh.2022.998714","journal-title":"Front Behav Neuroscie"},{"key":"2553_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2021.103963","volume":"146","author":"S Battaglia","year":"2021","unstructured":"Battaglia S, Serio G, Scarpazza C, D\u2019Ausilio A, Borgomaneri S (2021) Frozen in (e) motion: How reactive motor inhibition is influenced by the emotional content of stimuli in healthy and psychiatric populations. Behav Res Ther 146:103963","journal-title":"Behav Res Ther"},{"issue":"3","key":"2553_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0306-4522(94)90438-3","volume":"61","author":"R Beninger","year":"1994","unstructured":"Beninger R, Colton A, Ingles J, Jhamandas K, Boegman R (1994) Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry. Neuroscience 61(3):603\u2013612","journal-title":"Neuroscience"},{"issue":"1","key":"2553_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/070674370705200108","volume":"52","author":"MT Berlim","year":"2007","unstructured":"Berlim MT, Turecki G (2007) Definition, assessment, and staging of treatment\u2014resistant refractory major depression: a review of current concepts and methods. Canadian J Psychiatry 52(1):46\u201354","journal-title":"Canadian J Psychiatry"},{"issue":"8","key":"2553_CR11","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1038\/tp.2016.133","volume":"6","author":"L Brundin","year":"2016","unstructured":"Brundin L, Sellgren C, Lim C, Grit J, P\u00e5lsson E, Landen M, Samuelsson M, Lundgren K, Brundin P, Fuchs D (2016) An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation. Transl Psychiatry 6(8):e865\u2013e865","journal-title":"Transl Psychiatry"},{"key":"2553_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fncel.2014.00430","volume":"8","author":"F Calabrese","year":"2014","unstructured":"Calabrese F, Rossetti AC, Racagni G, Gass P, Riva MA, Molteni R (2014) Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci 8:430","journal-title":"Front Cell Neurosci"},{"key":"2553_CR13","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/149897","author":"MDP Carrera-Gonz\u00e1lez","year":"2022","unstructured":"Carrera-Gonz\u00e1lez MDP, Cant\u00f3n-Habas V, Rich-Ruiz M (2022) Aging, depression and dementia: the inflammatory process. Adv Clin Exp Med. https:\/\/doi.org\/10.17219\/acem\/149897","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"2553_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-89335-9","volume":"11","author":"F Cathomas","year":"2021","unstructured":"Cathomas F, Guetter K, Seifritz E, Klaus F, Kaiser S (2021) Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder. Sci Rep 11(1):1\u201310","journal-title":"Sci Rep"},{"issue":"6349","key":"2553_CR15","doi-asserted-by":"publisher","first-page":"eaff9794","DOI":"10.1126\/science.aaf9794","volume":"357","author":"I Cervenka","year":"2017","unstructured":"Cervenka I, Agudelo LZ, Ruas JL (2017) Kynurenines: Tryptophan\u2019s metabolites in exercise inflammation, and mental health. Science 357(6349):eaff9794","journal-title":"Science"},{"issue":"1","key":"2553_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-020-00266-0","volume":"18","author":"L-M Chen","year":"2021","unstructured":"Chen L-M, Bao C-H, Wu Y, Liang S-H, Wang D, Wu L-Y, Huang Y, Liu H-R, Wu H-G (2021) Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease. J Neuroinflammation 18(1):1\u201313","journal-title":"J Neuroinflammation"},{"key":"2553_CR17","doi-asserted-by":"publisher","DOI":"10.4137\/IJTR.S2097","author":"Y Chen","year":"2009","unstructured":"Chen Y, Guillemin GJ (2009) Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res. https:\/\/doi.org\/10.4137\/IJTR.S2097","journal-title":"Int J Tryptophan Res"},{"key":"2553_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuro.2012.11.007","volume":"34","author":"AL Col\u00edn-Gonz\u00e1lez","year":"2013","unstructured":"Col\u00edn-Gonz\u00e1lez AL, Maldonado PD, Santamar\u00eda A (2013) 3-Hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system. Neurotoxicology 34:189\u2013204","journal-title":"Neurotoxicology"},{"issue":"2","key":"2553_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/pcn.12944","volume":"74","author":"R Colle","year":"2020","unstructured":"Colle R, Masson P, Verstuyft C, F\u00e8ve B, Werner E, Boursier-Neyret C, Walther B, David DJ, Boniface B, Falissard B (2020) Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: a case\u2013control study. Psychiatry Clin Neurosci 74(2):112\u2013117","journal-title":"Psychiatry Clin Neurosci"},{"issue":"15","key":"2553_CR20","doi-asserted-by":"publisher","first-page":"8493","DOI":"10.3390\/ijms23158493","volume":"23","author":"AS Correia","year":"2022","unstructured":"Correia AS, Vale N (2022) Tryptophan metabolism in depression: a narrative review with a focus on serotonin and kynurenine pathways. Int J Mol Sci 23(15):8493","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2553_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0006-3223(02)01500-7","volume":"53","author":"JR Davidson","year":"2003","unstructured":"Davidson JR, Abraham K, Connor KM, McLeod MN (2003) Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiat 53(3):261\u2013264","journal-title":"Biol Psychiat"},{"issue":"5","key":"2553_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00131746-200509000-00004","volume":"11","author":"JP Docherty","year":"2005","unstructured":"Docherty JP, Sack DA, Roffman M, Finch M, Komorowski JR (2005) A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving\u00ae. J Psychiatric Pract 11(5):302\u2013314","journal-title":"J Psychiatric Pract"},{"issue":"5","key":"2553_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanct\u00f4t KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiat 67(5):446\u2013457","journal-title":"Biol Psychiat"},{"key":"2553_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv089","author":"AM Dugan","year":"2016","unstructured":"Dugan AM, Parrott JM, Redus L, Hensler JG, O\u2019Connor JC (2016) Low-level stress induces production of neuroprotective factors in wild-type but not BDNF+\/-mice: interleukinand kynurenic acid. Int J Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyv089","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"2553_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-73918-z","volume":"10","author":"H Erabi","year":"2020","unstructured":"Erabi H, Okada G, Shibasaki C, Setoyama D, Kang D, Takamura M, Yoshino A, Fuchikami M, Kurata A, Kato TA (2020) Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis. Sci Rep 10(1):1\u20138","journal-title":"Sci Rep"},{"key":"2553_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jad.2020.06.067","volume":"276","author":"PB Fitzgerald","year":"2020","unstructured":"Fitzgerald PB (2020) An update on the clinical use of repetitive transcranial magnetic stimulation in the treatment of depression. J Affect Disord 276:90\u2013103","journal-title":"J Affect Disord"},{"issue":"1\u20133","key":"2553_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jad.2010.11.035","volume":"131","author":"SB Fluitman","year":"2011","unstructured":"Fluitman SB, Heijnen CJ, Denys DA, Nolen WA, Balk FJ, Westenberg HG (2011) Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. J Affect Disord 131(1\u20133):388\u2013392","journal-title":"J Affect Disord"},{"key":"2553_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.721126","volume":"12","author":"JA Foster","year":"2021","unstructured":"Foster JA, Baker GB, Dursun SM (2021) The relationship between the gut microbiome-immune system-brain axis and major depressive disorder. Front Neurol 12:721126","journal-title":"Front Neurol"},{"key":"2553_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jpsychires.2017.05.004","volume":"92","author":"TFV Freire","year":"2017","unstructured":"Freire TFV, da Rocha NS, de Almeida Fleck MP (2017) The association of electroconvulsive therapy to pharmacological treatment and its influence on cytokines. J Psychiatr Res 92:205\u2013211","journal-title":"J Psychiatr Res"},{"issue":"2","key":"2553_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s43440-020-00202-2","volume":"73","author":"M Ga\u0142ecka","year":"2021","unstructured":"Ga\u0142ecka M, Bli\u017aniewska-Kowalska K, Maes M, Su K-P, Ga\u0142ecki P (2021) Update on the neurodevelopmental theory of depression: is there any \u2018unconscious code\u2019? Pharmacol Rep 73(2):346\u2013356","journal-title":"Pharmacol Rep"},{"key":"2553_CR31","doi-asserted-by":"publisher","DOI":"10.4137\/IJTR.S2469","author":"R Grant","year":"2009","unstructured":"Grant R, Coggan S, Smythe G (2009) The physiological action of picolinic acid in the human brain. Int J Tryptophan Res. https:\/\/doi.org\/10.4137\/IJTR.S2469","journal-title":"Int J Tryptophan Res"},{"issue":"8","key":"2553_CR32","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","volume":"279","author":"GJ Guillemin","year":"2012","unstructured":"Guillemin GJ (2012) Quinolinic acid, the inescapable neurotoxin. FEBS J 279(8):1356\u20131365","journal-title":"FEBS J"},{"key":"2553_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2015.02.029","volume":"48","author":"S Guloksuz","year":"2015","unstructured":"Guloksuz S, Arts B, Walter S, Drukker M, Rodriguez L, Myint A-M, Schwarz MJ, Ponds R, van Os J, Kenis G (2015) The impact of electroconvulsive therapy on the tryptophan\u2013kynurenine metabolic pathway. Brain Behav Immun 48:48\u201352","journal-title":"Brain Behav Immun"},{"issue":"2","key":"2553_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/YCT.0000000000000127","volume":"30","author":"S Guloksuz","year":"2014","unstructured":"Guloksuz S, Rutten BP, Arts B, van Os J, Kenis G (2014) The immune system and electroconvulsive therapy for depression. J ECT 30(2):132\u2013137","journal-title":"J ECT"},{"key":"2553_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3389\/fphys.2017.00559","volume":"8","author":"F Guo","year":"2017","unstructured":"Guo F, Lou J, Han X, Deng Y, Huang X (2017) Repetitive transcranial magnetic stimulation ameliorates cognitive impairment by enhancing neurogenesis and suppressing apoptosis in the hippocampus in rats with ischemic stroke. Front Physiol 8:559","journal-title":"Front Physiol"},{"key":"2553_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivim\u00e4ki M (2015) Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder. Brain Behav Immun 49:206\u2013215","journal-title":"Brain Behav Immun"},{"issue":"3","key":"2553_CR37","first-page":"280","volume":"55","author":"Y Hacimusalar","year":"2018","unstructured":"Hacimusalar Y, Esel E (2018) Suggested biomarkers for major depressive disorder. Arch Neuropsychiatry 55(3):280","journal-title":"Arch Neuropsychiatry"},{"issue":"11","key":"2553_CR38","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1038\/s41380-020-0685-9","volume":"25","author":"BD Hare","year":"2020","unstructured":"Hare BD, Duman RS (2020) Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions. Mol Psychiatry 25(11):2742\u20132758","journal-title":"Mol Psychiatry"},{"key":"2553_CR39","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/152350","author":"P Hepsomali","year":"2022","unstructured":"Hepsomali P, Coxon C (2022) Inflammation and diet: focus on mental and cognitive health. Adv Clin Exp Med. https:\/\/doi.org\/10.17219\/acem\/152350","journal-title":"Adv Clin Exp Med"},{"key":"2553_CR40","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.neubiorev.2020.08.010","volume":"118","author":"C Hunt","year":"2020","unstructured":"Hunt C, e Cordeiro TM, Suchting R, de Dios C, Leal VAC, Soares JC, Dantzer R, Teixeira AL, Selvaraj S, (2020) Effect of immune activation on the kynurenine pathway and depression symptoms\u2013a systematic review and meta-analysis. Neurosci Biobehav Rev 118:514\u2013523","journal-title":"Neurosci Biobehav Rev"},{"key":"2553_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","volume":"112","author":"PJ Kennedy","year":"2017","unstructured":"Kennedy PJ, Cryan JF, Dinan TG, Clarke G (2017) Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology 112:399\u2013412","journal-title":"Neuropharmacology"},{"issue":"2","key":"2553_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41380-019-0585-z","volume":"25","author":"M Kennis","year":"2020","unstructured":"Kennis M, Gerritsen L, van Dalen M, Williams A, Cuijpers P, Bockting C (2020) Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Mol Psychiatry 25(2):321\u2013338","journal-title":"Mol Psychiatry"},{"issue":"8","key":"2553_CR43","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/02698811211026426","volume":"35","author":"E Kopra","year":"2021","unstructured":"Kopra E, Mondelli V, Pariante C, Nikkheslat N (2021) Ketamine\u2019s effect on inflammation and kynurenine pathway in depression: a systematic review. J Psychopharmacol 35(8):934\u2013945","journal-title":"J Psychopharmacol"},{"issue":"5","key":"2553_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA K\u00f6hler","year":"2017","unstructured":"K\u00f6hler CA, Freitas TH, Maes Md, De Andrade N, Liu C, Fernandes B, Stubbs B, Solmi M, Veronese N, Herrmann N (2017) Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 135(5):373\u2013387","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"2553_CR45","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","volume":"179","author":"D Krause","year":"2011","unstructured":"Krause D, Suh H-S, Tarassishin L, Cui QL, Durafourt BA, Choi N, Bauman A, Cosenza-Nashat M, Antel JP, Zhao M-L (2011) The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1. Am J Pathol 179(3):1360\u20131372","journal-title":"Am J Pathol"},{"issue":"8","key":"2553_CR46","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00702-021-02363-7","volume":"128","author":"F Leblhuber","year":"2021","unstructured":"Leblhuber F, Geisler S, Ehrlich D, Steiner K, Reibnegger G, Fuchs D, Kurz K (2021) Repetitive transcranial magnetic stimulation in the treatment of resistant depression: changes of specific neurotransmitter precursor amino acids. J Neural Transm 128(8):1225\u20131231","journal-title":"J Neural Transm"},{"issue":"8","key":"2553_CR47","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00702-019-02037-5","volume":"126","author":"F Leblhuber","year":"2019","unstructured":"Leblhuber F, Steiner K, Fuchs D (2019) Treatment of patients with geriatric depression with repetitive transcranial magnetic stimulation. J Neural Transm 126(8):1105\u20131110","journal-title":"J Neural Transm"},{"issue":"1","key":"2553_CR48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/YCT.0b013e3181571abb","volume":"24","author":"K Lehtim\u00e4ki","year":"2008","unstructured":"Lehtim\u00e4ki K, Ker\u00e4nen T, Huuhka M, Palmio J, Hurme M, Leinonen E, Peltola J (2008) Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J ECT 24(1):88\u201391","journal-title":"J ECT"},{"issue":"5","key":"2553_CR49","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1007\/s12035-018-1283-6","volume":"56","author":"B Lima Giacobbo","year":"2019","unstructured":"Lima Giacobbo B, Doorduin J, Klein HC, Dierckx RA, Bromberg E, de Vries EF (2019) Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation. Mol Neurobiol 56(5):3295\u20133312","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2553_CR50","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/biomedicines10040849","volume":"10","author":"D Martos","year":"2022","unstructured":"Martos D, Tuka B, Tanaka M, V\u00e9csei L, Telegdy G (2022) Memory enhancement with kynurenic acid and its mechanisms in neurotransmission. Biomedicines 10(4):849","journal-title":"Biomedicines"},{"key":"2553_CR51","doi-asserted-by":"crossref","unstructured":"Marx W, McGuinness AJ, Rocks T, Ruusunen A, Cleminson J, Walker AJ, Gomes-da-Costa S, Lane M, Sanches M, Diaz AP (2020) The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies. Molecular psychiatry:1\u201321","DOI":"10.1038\/s41380-020-00951-9"},{"issue":"9","key":"2553_CR52","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/npp.2013.140","volume":"38","author":"AH Miller","year":"2013","unstructured":"Miller AH (2013) Conceptual confluence: the kynurenine pathway as a common target for ketamine and the convergence of the inflammation and glutamate hypotheses of depression. Neuropsychopharmacology 38(9):1607\u20131608","journal-title":"Neuropsychopharmacology"},{"key":"2553_CR53","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","volume":"277","author":"SM O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony SM, Clarke G, Borre Y, Dinan TG, Cryan J (2015) Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277:32\u201348","journal-title":"Behav Brain Res"},{"key":"2553_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","volume":"90","author":"K Ogyu","year":"2018","unstructured":"Ogyu K, Kubo K, Noda Y, Iwata Y, Tsugawa S, Omura Y, Wada M, Tarumi R, Plitman E, Moriguchi S (2018) Kynurenine pathway in depression: a systematic review and meta-analysis. Neurosci Biobehav Rev 90:16\u201325","journal-title":"Neurosci Biobehav Rev"},{"key":"2553_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.696059","author":"N Okamoto","year":"2021","unstructured":"Okamoto N, Natsuyama T, Igata R, Konishi Y, Tesen H, Ikenouchi A, Yoshimura R (2021) Associations between the kynurenine pathway, proinflammatory cytokines, and brain-derived neurotrophic factor in hospitalized patients with chronic schizophrenia: a preliminary study. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2021.696059","journal-title":"Front Psychiatry"},{"key":"2553_CR56","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","volume":"87","author":"EF Osimo","year":"2020","unstructured":"Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD (2020) Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun 87:901\u2013909","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2553_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.65","volume":"2","author":"C Otte","year":"2016","unstructured":"Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF (2016) Major depressive disorder. Nat Rev Dis Primers 2(1):1\u201320","journal-title":"Nat Rev Dis Primers"},{"key":"2553_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.896327","author":"N Petronijevi\u0107","year":"2022","unstructured":"Petronijevi\u0107 N, Lane H-Y, Radonji\u0107 NV (2022) Modulation of NMDA receptors: from bench side to clinical applications in psychiatry. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2022.896327","journal-title":"Front Psychiatry"},{"issue":"1","key":"2553_CR59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41386-021-01101-7","volume":"47","author":"DA Pizzagalli","year":"2022","unstructured":"Pizzagalli DA, Roberts AC (2022) Prefrontal cortex and depression. Neuropsychopharmacology 47(1):225\u2013246","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"2553_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/antiox11010031","volume":"11","author":"D Ram\u00edrez Ortega","year":"2021","unstructured":"Ram\u00edrez Ortega D, UgaldeMu\u00f1iz PE, Blanco Ayala T, V\u00e1zquez Cervantes GI, Lugo Huitr\u00f3n R, Pineda B, Gonz\u00e1lez Esquivel DF, P\u00e9rez de la Cruz G, Pedraza Chaverr\u00ed J, S\u00e1nchez Chapul L (2021) On the antioxidant properties of L-kynurenine: An efficient ROS scavenger and enhancer of rat brain antioxidant defense. Antioxidants 11(1):31","journal-title":"Antioxidants"},{"key":"2553_CR61","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpsychires.2015.05.007","volume":"68","author":"GZ R\u00e9us","year":"2015","unstructured":"R\u00e9us GZ, Jansen K, Titus S, Carvalho AF, Gabbay V, Quevedo J (2015) Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies. J Psychiatr Res 68:316\u2013328","journal-title":"J Psychiatr Res"},{"issue":"3","key":"2553_CR62","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/YCT.0b013e3182843942","volume":"29","author":"A Rotter","year":"2013","unstructured":"Rotter A, Biermann T, Stark C, Decker A, Demling J, Zimmermann R, Sperling W, Kornhuber J, Henkel A (2013) Changes of cytokine profiles during electroconvulsive therapy in patients with major depression. J ECT 29(3):162\u2013169","journal-title":"J ECT"},{"issue":"8","key":"2553_CR63","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00702-008-0052-5","volume":"115","author":"E R\u00f3zsa","year":"2008","unstructured":"R\u00f3zsa E, Robotka H, V\u00e9csei L, Toldi J (2008) The Janus-face kynurenic acid. J Neural Transm 115(8):1087\u20131091","journal-title":"J Neural Transm"},{"issue":"11","key":"2553_CR64","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am J Psychiatry 163(11):1905\u20131917","journal-title":"Am J Psychiatry"},{"key":"2553_CR65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbi.2019.10.005","volume":"83","author":"KM Ryan","year":"2020","unstructured":"Ryan KM, Allers KA, McLoughlin DM, Harkin A (2020) Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy. Brain Behav Immun 83:153\u2013162","journal-title":"Brain Behav Immun"},{"issue":"9","key":"2553_CR66","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nn1969","volume":"10","author":"A Sahay","year":"2007","unstructured":"Sahay A, Hen R (2007) Adult hippocampal neurogenesis in depression. Nat Neurosci 10(9):1110\u20131115","journal-title":"Nat Neurosci"},{"issue":"1","key":"2553_CR67","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/molecules23010191","volume":"23","author":"K Sas","year":"2018","unstructured":"Sas K, Szab\u00f3 E, V\u00e9csei L (2018) Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection. Molecules 23(1):191","journal-title":"Molecules"},{"key":"2553_CR68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuroscience.2017.10.006","volume":"367","author":"K Sathyasaikumar","year":"2017","unstructured":"Sathyasaikumar K, Tararina M, Wu H-Q, Neale S, Weisz F, Salt T, Schwarcz R (2017) Xanthurenic acid formation from 3-hydroxykynurenine in the mammalian brain: neurochemical characterization and physiological effects. Neuroscience 367:85\u201397","journal-title":"Neuroscience"},{"issue":"1","key":"2553_CR69","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J (2020) The kynurenine pathway: a finger in every pie. Mol Psychiatry 25(1):131\u2013147","journal-title":"Mol Psychiatry"},{"issue":"2","key":"2553_CR70","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/npp.2014.194","volume":"40","author":"J Savitz","year":"2015","unstructured":"Savitz J, Drevets WC, Smith CM, Victor TA, Wurfel BE, Bellgowan PS, Bodurka J, Teague TK, Dantzer R (2015) Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology 40(2):463\u2013471","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"2553_CR71","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu H-Q (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13(7):465\u2013477","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2553_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0517-7","volume":"13","author":"L Schwieler","year":"2016","unstructured":"Schwieler L, Samuelsson M, Frye MA, Bhat M, Schuppe-Koistinen I, Jungholm O, Johansson AG, Land\u00e9n M, Sellgren CM, Erhardt S (2016) Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients. J Neuroinflammation 13(1):1\u201310","journal-title":"J Neuroinflammation"},{"key":"2553_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716980","author":"K Skorobogatov","year":"2021","unstructured":"Skorobogatov K, De Picker L, Verkerk R, Coppens V, Leboyer M, M\u00fcller N, Morrens M (2021) Brain versus blood: a systematic review on the concordance between peripheral and central kynurenine pathway measures in psychiatric disorders. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.716980","journal-title":"Front Immunol"},{"key":"2553_CR74","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S114542","author":"R Strawbridge","year":"2017","unstructured":"Strawbridge R, Young AH, Cleare AJ (2017) Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatri Dis Treat. https:\/\/doi.org\/10.2147\/NDT.S114542","journal-title":"Neuropsychiatri Dis Treat"},{"issue":"2","key":"2553_CR75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s43440-020-00067-5","volume":"72","author":"M Tanaka","year":"2020","unstructured":"Tanaka M, Boh\u00e1r Z, Martos D, Telegdy G, V\u00e9csei L (2020) Antidepressant-like effects of kynurenic acid in a modified forced swim test. Pharmacol Rep 72(2):449\u2013455","journal-title":"Pharmacol Rep"},{"key":"2553_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-022-02513-5","author":"M Tanaka","year":"2022","unstructured":"Tanaka M, Spekker E, Szab\u00f3 \u00c1, Poly\u00e1k H, V\u00e9csei L (2022a) Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents\u2014in celebration of 80th birthday of Professor Peter Riederer. J Neural Transmission. https:\/\/doi.org\/10.1007\/s00702-022-02513-5","journal-title":"J Neural Transmission"},{"issue":"16","key":"2553_CR77","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.3390\/cells11162607","volume":"11","author":"M Tanaka","year":"2022","unstructured":"Tanaka M, Szab\u00f3 \u00c1, Spekker E, Poly\u00e1k H, T\u00f3th F, V\u00e9csei L (2022b) Mitochondrial impairment: a common motif in neuropsychiatric presentation? The link to the tryptophan-kynurenine metabolic system. Cells 11(16):2607","journal-title":"Cells"},{"issue":"7","key":"2553_CR78","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/biomedicines9070734","volume":"9","author":"M Tanaka","year":"2021","unstructured":"Tanaka M, T\u00f3th F, Poly\u00e1k H, Szab\u00f3 \u00c1, M\u00e1ndi Y, V\u00e9csei L (2021) Immune influencers in action: metabolites and enzymes of the tryptophan-kynurenine metabolic pathway. Biomedicines 9(7):734","journal-title":"Biomedicines"},{"issue":"8","key":"2553_CR79","doi-asserted-by":"publisher","first-page":"775","DOI":"10.17219\/acem\/139572","volume":"30","author":"M Tanaka","year":"2021","unstructured":"Tanaka M, V\u00e9csei L (2021) Monitoring the kynurenine system: concentrations, ratios or what else? Adv Clin Exp Med 30(8):775\u2013778","journal-title":"Adv Clin Exp Med"},{"key":"2553_CR80","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jpsychires.2021.04.009","volume":"138","author":"H Tateishi","year":"2021","unstructured":"Tateishi H, Setoyama D, Kang D, Matsushima J, Kojima R, Fujii Y, Mawatari S, Kikuchi J, Sakemura Y, Fukuchi J (2021) The changes in kynurenine metabolites induced by rTMS in treatment-resistant depression: a pilot study. J Psychiatr Res 138:194\u2013199","journal-title":"J Psychiatr Res"},{"issue":"1","key":"2553_CR81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1440-1819.2010.02170.x","volume":"65","author":"E Ueyama","year":"2011","unstructured":"Ueyama E, Ukai S, Ogawa A, Yamamoto M, Kawaguchi S, Ishii R, Shinosaki K (2011) Chronic repetitive transcranial magnetic stimulation increases hippocampal neurogenesis in rats. Psychiatry Clin Neurosci 65(1):77\u201381","journal-title":"Psychiatry Clin Neurosci"},{"issue":"7","key":"2553_CR82","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1038\/tp.2015.100","volume":"5","author":"EM van Buel","year":"2015","unstructured":"van Buel EM, Patas K, Peters M, Bosker FJ, Eisel UL, Klein HC (2015) Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all? Transl Psychiatry 5(7):e609\u2013e609","journal-title":"Transl Psychiatry"},{"key":"2553_CR83","unstructured":"WHO (2017) Depression and other common mental disorders: global health estimates. World Health Organization,"},{"issue":"1","key":"2553_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-020-03030-z","volume":"21","author":"LM Williams","year":"2021","unstructured":"Williams LM, Coman JT, Stetz PC, Walker NC, Kozel FA, George MS, Yoon J, Hack LM, Madore MR, Lim KO (2021) Identifying response and predictive biomarkers for transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression. BMC Psychiatry 21(1):1\u201317","journal-title":"BMC Psychiatry"},{"issue":"1","key":"2553_CR85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brs.2017.10.013","volume":"11","author":"A Yrondi","year":"2018","unstructured":"Yrondi A, Sporer M, Peran P, Schmitt L, Arbus C, Sauvaget A (2018) Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review. Brain Stimul 11(1):29\u201351","journal-title":"Brain Stimul"},{"issue":"11","key":"2553_CR86","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.3390\/ijms22115903","volume":"22","author":"F Z\u00e1dor","year":"2021","unstructured":"Z\u00e1dor F, Joca S, Nagy-Gr\u00f3cz G, Dvor\u00e1csk\u00f3 S, Sz\u0171cs E, T\u00f6mb\u00f6ly C, Benyhe S, V\u00e9csei L (2021) Pro-Inflammatory Cytokines: potential links between the endocannabinoid system and the kynurenine pathway in depression. Int J Mol Sci 22(11):5903","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2553_CR87","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2174\/1570159X14666160119094646","volume":"14","author":"J-c Zhang","year":"2016","unstructured":"Zhang J-c, Yao W, Hashimoto K (2016) Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets. Curr Neuropharmacol 14(7):721\u2013731","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"2553_CR88","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1177\/0300060518817417","volume":"47","author":"X Zhao","year":"2019","unstructured":"Zhao X, Li Y, Tian Q, Zhu B, Zhao Z (2019) Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1\u03b2 and tumor necrosis factor-\u03b1 in elderly patients with refractory depression. J Int Med Res 47(5):1848\u20131855","journal-title":"J Int Med Res"}],"updated-by":[{"DOI":"10.1007\/s00702-022-02573-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000}}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-022-02553-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-022-02553-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-022-02553-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T11:08:14Z","timestamp":1671016094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-022-02553-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,5]]},"references-count":88,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2553"],"URL":"https:\/\/doi.org\/10.1007\/s00702-022-02553-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00702-022-02573-7","asserted-by":"object"}]},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,5]]},"assertion":[{"value":"12 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00702-022-02573-7","URL":"https:\/\/doi.org\/10.1007\/s00702-022-02573-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study began and performed with the approval of GUFM Clinical Research Ethics Committee (Date\/Number: 12.02.2018\/99, and 24.09.2018\/688).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}